H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 89 Citations 37,284 361 World Ranking 6293 National Ranking 68

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

His primary areas of investigation include Multiple sclerosis, Internal medicine, Immunology, Surgery and Placebo. His Multiple sclerosis study combines topics in areas such as Central nervous system disease, Disease, Pathology, Intensive care medicine and Physical therapy. His work deals with themes such as Gastroenterology, Expanded Disability Status Scale and Oncology, which intersect with Internal medicine.

His work in Immunology tackles topics such as Standardized mortality ratio which are related to areas like Retrospective cohort study. The study incorporates disciplines such as Stroke, Spinal cord compression and Anesthesia in addition to Surgery. His Placebo research is multidisciplinary, incorporating elements of Clinical endpoint, Randomized controlled trial, Clinical trial and Hazard ratio.

His most cited work include:

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (1970 citations)
  • Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (1618 citations)
  • Defining the clinical course of multiple sclerosis: The 2013 revisions (1374 citations)

What are the main themes of his work throughout his whole career to date?

Per Soelberg Sørensen mostly deals with Multiple sclerosis, Internal medicine, Immunology, Disease and Expanded Disability Status Scale. In his study, White matter is inextricably linked to Pathology, which falls within the broad field of Multiple sclerosis. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Placebo, Surgery and Oncology.

Per Soelberg Sørensen interconnects Cladribine, Adverse effect, Randomized controlled trial and Clinical trial in the investigation of issues within Placebo. As part of his studies on Immunology, Per Soelberg Sørensen often connects relevant subjects like Central nervous system. His Natalizumab research includes elements of Fingolimod and Glatiramer acetate.

He most often published in these fields:

  • Multiple sclerosis (65.18%)
  • Internal medicine (33.18%)
  • Immunology (21.88%)

What were the highlights of his more recent work (between 2017-2021)?

  • Multiple sclerosis (65.18%)
  • Internal medicine (33.18%)
  • Disease (9.65%)

In recent papers he was focusing on the following fields of study:

Multiple sclerosis, Internal medicine, Disease, Expanded Disability Status Scale and Cladribine are his primary areas of study. Per Soelberg Sørensen combines Multiple sclerosis and In patient in his studies. The various areas that Per Soelberg Sørensen examines in his Internal medicine study include Placebo and Oncology.

His study in the fields of Demyelinating disease under the domain of Disease overlaps with other disciplines such as Multidisciplinary approach. His Expanded Disability Status Scale study incorporates themes from Interquartile range, Cognition, Proportional hazards model, Propensity score matching and Hazard ratio. His study in Cladribine is interdisciplinary in nature, drawing from both Magnetic resonance imaging, CLARITY and Immune system.

Between 2017 and 2021, his most popular works were:

  • ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis: (199 citations)
  • Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study. (109 citations)
  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. (67 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

Per Soelberg Sørensen mainly investigates Multiple sclerosis, Internal medicine, Cladribine, Placebo and Confidence interval. His studies in Multiple sclerosis integrate themes in fields like Clinical trial, Pharmacological treatment, Guideline, Intensive care medicine and Disease. His studies deal with areas such as Dimethyl fumarate, Genotyping, Human leukocyte antigen and Interferon beta as well as Internal medicine.

The concepts of his Cladribine study are interwoven with issues in Immune system, Magnetic resonance imaging and Oncology. His work carried out in the field of Placebo brings together such families of science as Gastroenterology and Randomized controlled trial. Per Soelberg Sørensen has researched Confidence interval in several fields, including Expanded Disability Status Scale, Epidemiology, Proportional hazards model and Cohort study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson;Brenda L. Banwell;Frederik Barkhof;Frederik Barkhof;William M. Carroll.
Lancet Neurology (2017)

2367 Citations

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer.
Nature (2011)

2262 Citations

Defining the clinical course of multiple sclerosis: The 2013 revisions

Fred D. Lublin;Stephen C. Reingold;Jeffrey A. Cohen;Gary R. Cutter.
Neurology (2014)

2122 Citations

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study.

Giancarlo Comi;Massimo Filippi;Frederik Barkhof;Luca Durelli.
The Lancet (2001)

1405 Citations

The relation between inflammation and neurodegeneration in multiple sclerosis brains

Josa M. Frischer;Stephan Bramow;Assunta Dal-Bianco;Claudia F. Lucchinetti.
Brain (2009)

1403 Citations

The Changing Demographic Pattern of Multiple Sclerosis Epidemiology

Nils Iørgen Koch-Henriksen;Per Soelberg Sørensen.
Lancet Neurology (2010)

1131 Citations

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis.
Nature Genetics (2013)

873 Citations

Remyelination is extensive in a subset of multiple sclerosis patients

Peter Patrikios;Christine Stadelmann;Alexandra Kutzelnigg;Helmut Rauschka.
Brain (2006)

847 Citations

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

Gavin Giovannoni;Giancarlo Comi;Stuart Cook;Kottil Rammohan.
The New England Journal of Medicine (2010)

795 Citations

Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood.

Anders Koch;Mads Melbye;Per Sørensen;Preben Homøe.
JAMA (2001)

547 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Per Soelberg Sørensen

Xavier Montalban

Xavier Montalban

Autonomous University of Barcelona

Publications: 185

Gavin Giovannoni

Gavin Giovannoni

Queen Mary University of London

Publications: 160

Frederik Barkhof

Frederik Barkhof

University College London

Publications: 151

Ludwig Kappos

Ludwig Kappos

University Hospital of Basel

Publications: 146

Massimo Filippi

Massimo Filippi

Vita-Salute San Raffaele University

Publications: 143

Giancarlo Comi

Giancarlo Comi

Vita-Salute San Raffaele University

Publications: 126

Jan Hillert

Jan Hillert

Karolinska Institute

Publications: 121

Friedemann Paul

Friedemann Paul

Max Delbrück Center for Molecular Medicine

Publications: 115

Helmut Butzkueven

Helmut Butzkueven

Monash University

Publications: 105

Bianca Weinstock-Guttman

Bianca Weinstock-Guttman

University at Buffalo, State University of New York

Publications: 105

Hans Lassmann

Hans Lassmann

Medical University of Vienna

Publications: 104

Hans-Peter Hartung

Hans-Peter Hartung

Heinrich Heine University Düsseldorf

Publications: 103

Robert Zivadinov

Robert Zivadinov

University at Buffalo, State University of New York

Publications: 101

Heinz Wiendl

Heinz Wiendl

University of Münster

Publications: 99

Maria Trojano

Maria Trojano

University of Bari Aldo Moro

Publications: 96

Something went wrong. Please try again later.